Gastrointestinal symptoms are associated with a lower risk of hospitalization and mortality and outcomes in COVID-19

Table 4 Comparison of deaths, hospitalization, and prolong hospitalization according to different symptoms subgroups

	Total (n = 42,964)	Group 1 (n = 1572)	Group 2 (n = 28,940)	Group 3 (n = 2615)	Group 4 (n = 9837)	P value
Death	3794(8.83)	80(5.08)	2787(9.63)	313(11.97)	614 (6.24)	0.001
Hospitalization	22,162(52.88)	750(47.7)	15,505(53.5)	1603(61)	4304(43.7)	0.001
Hospital stays^a, day	8.21 ± 8.92	7.30 ± 6.63	8.30 ± 8.30	7.53 ± 6.24	8.14 ± 9.5	0.001

	Total (n = 22,162)	Group 1 (n = 750)	Group 2 (n = 15,505)	Group 3 (n = 1603)	Group 4 (n = 4304)	P value
Prolong hospitalization^a (≥ median 6 days)	9821(23.0)	262(34.9)	7083(45.6)	687(42.8)	1789(41.5)	0.001

Continuous variables were reported as mean ± standard deviations (SD), and qualitative variables were reported as frequency (%). To comparison of qualitative variables between four groups, the Chi-square test was used
Group 1: Patients with Gastrointestinal symptoms; Group 2: Patients with respiratory symptoms; Group 3: Patients with both symptoms: Group 4: Patients with other symptoms
^aWas reported for hospitalized patients (n = 22,162)

ISSN: 1471-230X